In some breast cancer models, inhibition of Src activity suppresses the transformed phenotype of breast cancer cell lines [14] and restores tamoxifen sensitivity to tamoxifen-resistant breast cancer cell lines [15], suggesting it may be a useful target for therapy. The gene discussed is SRC; the disease is breast carcinoma.